Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women

Annals of Nutrition and Metabolism

Volumn 62, Issue 2, 2013, Pages 158-163

  Moon, Seong Su ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Metabolic syndrome; Nonalcoholic fatty liver disease; Postmenopause; Uric acid

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; BODY MASS; DYSLIPIDEMIA; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; SMOKING; URIC ACID BLOOD LEVEL; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HYPERTENSION; KOREAN (PEOPLE); MEDICAL HISTORY; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; RETROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ADULT; ALANINE TRANSAMINASE; ASIAN CONTINENTAL ANCESTRY GROUP; ASPARTATE AMINOTRANSFERASES; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CREATININE; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; LIVER; LOGISTIC MODELS; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; URIC ACID;

EID: 84873585722     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000346202     Document Type: Article

References (32)

1. Loguercio C, De Simone T, D'Auria MV, de Sio I, Federico A, Tuccillo C, Abbatecola AM, Del Vecchio Blanco C: Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. Dig Liver Dis 2004; 36: 398-405.
2. Loguercio C, De Girolamo V, de Sio I, Tuccillo C, Ascione A, Baldi F, Budillon G, Cimino L, Di Carlo A, Di Marino MP, Morisco F, Picciotto F, Terracciano L, Vecchione R, Verde V, Del Vecchio Blanco C: Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 2001; 35: 568-574.
3. Scorletti E, Calder PC, Byrne CD: Non-alcoholic fatty liver disea-se and cardiovascular risk: metabolic aspects and novel treatments. Endocrine 2011; 40: 332-343.
4. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
5. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, Wasada T: Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005; 22: 1141-1145.
6. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH: The metabolic syndrome. Endocr Rev 2008; 29: 777-822.
7. Bray GA, Bellanger T: Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 2006; 29: 109-117.
8. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M: Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004; 4: 9.
9. Feig DI, Kang DH, Johnson RJ: Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
10. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY, Kim SW, Ryu SH, Keum DG: Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69: 928-933.
11. Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, Mancini M, Trevisan M: Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens 1994; 8: 677-681.
12. Xu C, Yu C, Xu L, Miao M, Li Y: High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS One 2010; 5:e11578.
13. Li Y, Xu C, Yu C, Xu L, Miao M: Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol 2009; 50: 1029-1034.
14. Lee JW, Cho YK, Ryan M, Kim H, Lee SW, Chang E, Joo KJ, Kim JT, Kim BS, Sung KC: Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver 2010; 4: 378-383.
15. Abuja PM: Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein. FEBS Lett 1999; 446: 305-308.
16. Patterson RA, Horsley ET, Leake DS: Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid. J Lipid Res 2003; 44: 512-521.
17. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI, Keum DK, Kim BI: Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006; 21: 138-143.
18. Clark JM, Brancati FL, Diehl AM: Nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 1649-1657.
19. Suzuki A, Abdelmalek MF: Nonalcoholic fatty liver disease in women. Womens Health (Lond Engl) 2009; 5: 191-203.
20. 2000 World Health Organization: The Asia-Pacific Perspective: redefining obesity and its treatment. Sydney, Health Communication.
21. Sanyal AJ: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725.
22. Joy D, Thava VR, Scott BB: Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539-543.
23. Lazo M, Clark JM: The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28: 339-350.
24. Lewis JR, Mohanty SR: Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010; 55: 560-578.
25. Krawczyk M, Bonfrate L, Portincasa P: Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 2010; 24: 695-708 .
26. Trayhurn P, Wood IS: Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005; 33: 1078-1081.
27. Trayhurn P: Adipose tissue in obesity-an inflammatory issue. Endocrinology 2005; 146: 1003-1005.
28. Quinones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E: Effect of insulin on uric acid excretion in humans. Am J Physiol 1995; 268:E1-E5.
29. Modan M, Halkin H, Karasik A, Lusky A: Elevated serum uric acid-a facet of hyperinsulinaemia. Diabetologia 1987; 30: 713-718.
30. Dawson J, Walters M: Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol 2006; 62: 633-644.
31. Hwang IC, Suh SY, Suh AR, Ahn HY: The relationship between normal serum uric acid and nonalcoholic fatty liver disease. J Korean Med Sci 2011; 26: 386-391.
32. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos Nutrition and Liver Study. Hepatology 2005; 42: 44-52.